Epanutin ® Ready Mixed Parenteral 250 mg/5 ml Injection

    Epanutin ® Ready Mixed Parenteral 250 mg/5 ml Injection

    S3


    1. What EPANUTIN READY MIXED PARENTERAL is and what it is used for

    EPANUTIN READY MIXED PARENTERAL belongs to a group of medicines known as anti-epileptic medicines. EPANUTIN READY MIXED PARENTERAL can be used to prevent and treat seizures when the oral route is not suitable. It is used to:

    • Prevent and treat seizures during or after brain surgery
    • Control severe epileptic seizures or fits (status epilepticus)

    2. What you need to know before you are given EPANUTIN READY MIXED PARENTERAL

    EPANUTIN READY MIXED PARENTERAL should not be administered to you:

    • If you are hypersensitive (allergic) to phenytoin or any of the other ingredients of EPANUTIN READY MIXED PARENTERAL (listed in section 6), or other hydantoin medicines.
    • If you have porphyria (an inherited disease that affects haemoglobin biosynthesis).
    • If you suffer from certain conditions that affect the heart rhythm, for example a decreased heart rate (sinus bradycardia), heart block (sinoatrial block or A-V block) or Stokes-Adams syndrome.
    • If you are also taking medicines used for HIV infection.

    Warnings and precautions

    Tell your doctor or health care provider before being given the injection:

    • If you are alcohol dependant.
    • There is a risk of harm to the unborn child if EPANUTIN READY MIXED PARENTERAL is used during pregnancy. Women of childbearing age should use effective contraception during treatment with EPANUTIN READY MIXED PARENTERAL (see Pregnancy and breastfeeding).
    • Black patients may be at greater risk of liver problems, serious skin reactions and allergic reactions.
    • Some patients being treated with EPANUTIN READY MIXED PARENTERAL have had thoughts of harming or killing themselves. If at any time you have these thoughts, immediately contact your doctor.
    • If you have experienced irritation, inflammation, tenderness, dying or sloughing of skin cells at the site where EPANUTIN READY MIXED PARENTERAL was injected, or you have experienced discolouration, pain or swelling of the skin away from the site of injection. These symptoms may be minor but can also be serious. These may be signs of a condition known as Purple Glove Syndrome.
    • If you have ever experienced a serious hypersensitivity reaction which includes skin rash, fever, swollen glands, increase in a type of white blood cell (eosinophilia) and inflammation of the internal organs when you have previously been exposed to certain medicines such as EPANUTIN READY MIXED PARENTERAL. This reaction is called drug rash with eosinophilia symptoms (DRESS). If you have experienced any of these symptoms, tell your doctor immediately.
    • Potentially life-threatening skin rashes (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported with the use of EPANUTIN READY MIXED PARENTERAL, appearing initially as reddish target-like spots or circular patches often with central blisters on the trunk. Additional signs to look for include ulcers in the mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes). These potentially life-threatening skin rashes are often accompanied by flu-like symptoms.
    • The rash may progress to widespread blistering or peeling of the skin. The highest risk for occurrence of serious skin reactions is within the first weeks of treatment. If you have developed Stevens-Johnson syndrome or toxic epidermal necrolysis with the use of EPANUTIN READY MIXED PARENTERAL, you must not be re-started on EPANUTIN READY MIXED PARENTERAL at any time. If you develop a rash or these skin symptoms, stop receiving EPANUTIN READY MIXED PARENTERAL, seek urgent advice from a doctor and tell him that you are taking this medicine.
    • If you are of Asian ancestry and tests have shown that you carry the genetic variant HLA-B*1502.
    • If you suffer from liver disease.

    3. How to receive EPANUTIN READY MIXED PARENTERAL

    You will not be expected to give yourself EPANUTIN READY MIXED PARENTERAL. It will be given to you by a person who is qualified to do so.

    Use in status epilepticus

    The dose that is appropriate for you will be determined by your doctor. If you receive more EPANUTIN READY MIXED PARENTERAL than you should. Since a health care provider will administer EPANUTIN READY MIXED PARENTERAL, he/she will control the dosage. However, in the event of overdosage, your doctor will manage the overdosage. The initial symptoms of overdosage are involuntary eye movement, the loss of full control of bodily movements, and difficulty with speaking. Other symptoms of overdosage include tremor, overactive or overresponsive reflexes, tiredness, drowsiness, slurred speech, blurred vision, nausea and vomiting.

    If you forget to receive EPANUTIN READY MIXED PARENTERAL. Since a health care provider will administer EPANUTIN READY MIXED PARENTERAL, it is unlikely that the dose will be missed. If you stop receiving EPANUTIN READY MIXED PARENTERAL. Treatment with EPANUTIN READY MIXED PARENTERAL should not be stopped abruptly because of the possibility of increased seizure frequency. If the doctor decides to reduce the dose, stop treatment or change your medication, this should be done gradually. However, in the event of an allergic or hypersensitivity reaction, rapid substitution of alternative therapy may be necessary.

    4. Possible side effects

    EPANUTIN READY MIXED PARENTERAL can have side effects. Not all side effects reported for EPANUTIN READY MIXED PARENTERAL are included in this leaflet. Should your general health worsen or if you experience any untoward effects while receiving EPANUTIN READY MIXED PARENTERAL, please consult your health care provider for advice.

    If any of the following happens, stop receiving EPANUTIN READY MIXED PARENTERAL and tell your doctor immediately or go to the casualty department at your nearest hospital:

    • Swelling of the hands, feet, ankles, face, lips, mouth or throat, which may cause difficulty in swallowing or breathing.
    • Rash or itching.
    • Fainting.

    These are all very serious side effects. If you have them, you may have had a serious allergic reaction to EPANUTIN READY MIXED PARENTERAL. You may need urgent medical attention or hospitalisation.

    Tell your doctor immediately or go to the casualty department at your nearest hospital if you notice any of the following:

    • Chest pain and difficulty breathing.
    • Central nervous system depression.
    • Many sorts of skin rash, sometimes accompanied by fever, may occur with the use of EPANUTIN READY MIXED PARENTERAL. Some are minor (e.g. measles-like or mild dermatitis). Rash may also be a first sign of other side effects of EPANUTIN READY MIXED PARENTERAL. If you get a rash, your doctor may advise you to stop taking EPANUTIN READY MIXED PARENTERAL until it clears up. If the rash recurs, does not clear up or a serious reaction is suspected, your doctor may advise you not to take EPANUTIN again.
    • Liver failure, hepatitis (inflammation of the liver) or liver damage which may be recognised by yellowing of the skin and whites of the eyes and changes in liver function.

    These are all serious side effects. You may need urgent medical attention.

    Tell your doctor if you notice any of the following:

    Frequent side effects

    • Dizziness or vertigo, unusual eye movements, pins and needles.
    • Confusion, sleeplessness, nervousness.
    • Unsteadiness or difficulty in controlling movements, slurred speech, abnormal or uncoordinated movements, headaches.
    • Vertigo (dizziness).
    • Low blood pressure.
    • Nausea, vomiting.
    • Muscle twitching.
    • Local irritation, inflammation, tenderness or shedding of dead skin cells. Discolouration, pain or swelling of the skin away from the site of injection may also occur. These symptoms may be minor but can also be serious and are signs of a condition known as Purple Glove Syndrome.

    Less frequent side effects

    • Abnormalities of the blood, including decreases in the number of red cells, white cells or platelets (parts of the blood which help it clot). The first signs you might notice could be bruising, fever, pallor or sore throat. Your doctor may take regular blood samples to test for this.
    • Swelling of the lymph glands (a part of your body’s natural defence system) and other disorders of the lymph glands may occur. This may be accompanied by fever or rash and may affect your liver but may also be a sign of a problem with your lymph glands.
    • Abnormality or difficulty with muscle movement, including jerky involuntary movements, muscular spasm and abnormal posture, shaking, numbness, loss of feeling in the hands and feet. Things may also taste different.
    • Constipation, enlargement of the gums and lips.
    • Abnormal body or facial hair.
    • Changes in facial features, swelling of your gums and/or lips, inflammation in various parts of your body including the joints, skin, kidneys, a condition known as systemic lupus erythematosus, may occur.
    • Changes in the shape of the penis and painful erection (Peyronie’s disease).
    • Antibody abnormalities. EPANUTIN READY MIXED PARENTERAL may alter the amount of vitamin D in your body. If you also do not get enough vitamin D in your diet or from exposure to sunlight, you may suffer from bone pain or fractures. Rickets (abnormal development of bone) may occur if this effect is prolonged.

    If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.

    Reporting of side effects

    If you get side effects, talk to your doctor, or pharmacist or nurse. You can also report side effects to SAHPRA via the Med Safety APP (Medsafety X SAHPRA) and eReporting platform (who-umc.org) found on SAHPRA website. By reporting side effects, you can help provide more information on the safety of EPANUTIN READY MIXED PARENTERAL.

    5. How to store EPANUTIN READY MIXED PARENTERAL

    The storage of EPANUTIN READY MIXED PARENTERAL will not be your responsibility. However, it should be stored at or below 25 °C and protected from light and excessive heat.

    Important Disclaimer

    The Epanutin ® Ready Mixed Parenteral 250 mg/5 ml Injection professional information leaflet below is the property of Viatris Healthcare and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Epanutin ® Ready Mixed Parenteral 250 mg/5 ml Injection
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites